Sage Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022

Rhea-AI Summary

Sage Therapeutics, Inc. (NASDAQ: SAGE) announced a live webcast scheduled for February 24, 2022, at 8:00 a.m. ET to discuss its fourth quarter and full year 2021 financial results. The event will cover recent business updates and can be accessed via Sage's investor page. A replay will be available two hours post-event for 30 days. Sage focuses on developing innovative therapies for severe brain disorders, aiming to enhance treatment approaches in depression and neurology.

Positive

• Plans to discuss fourth quarter and full year 2021 financial results, indicating transparency in earnings.
• Focus on transformative therapies in brain health, potentially enhancing market perception.

Negative

• None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Thursday, February 24, 2022 at 8:00 a.m. ET to announce fourth quarter and full year 2021 financial results and discuss recent business updates.

The webcast can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220209005802/en/

Investor Contact

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.com

Media Contact

Maureen L. Suda

617-949-4289

maureen.suda@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

When will Sage Therapeutics announce its financial results for 2021?

Sage Therapeutics will announce its financial results on February 24, 2022.

How can I access the Sage Therapeutics webcast?

The webcast can be accessed on Sage's investor page at investor.sagerx.com.

What is the focus of Sage Therapeutics?

Sage Therapeutics focuses on developing therapies for debilitating brain disorders.

Will the Sage Therapeutics webcast be available for replay?

Yes, a replay of the webcast will be available approximately two hours after the event.